Maui Wowie lab report

Most often, Maui Wowie reached the 20% total THC line in Washington; across all 190 flower tests, 22% reached that threshold or higher (about 2 in 10), the share at 25% or higher was 1.1% (about 1 in 91), and the 30% or higher share was 0%; median THC was 18.18%.¹

In Washington, 51% of 41 tests were at the 20% line or higher, with a median of 20.03%; in Maryland, the comparable share was 12% of 124, with a median of 17.69%.¹ Those differences reflect tested supply, growers, labs and state rules, not only the plant.

Yes, for Maui Wowie, every single THC figure we checked sat above the lab median: three of three were higher than 18.18%, and the top one was Homegrown Cannabis Co. at 20%; only 22% of tests reached that line or higher (about 2 in 10).^1,3

At the low end, Leafly listed 19%; 34% of lab results were at least that high (about 3 in 10).^1,4 For range claims, 16–24% from Weedmaps bracketed 81% of results, compared with 22% for 20–28% from AllBud.^1,5,6

A strain-page number is not a batch result; for the jar in hand, read that batch's certificate of analysis.

Among qualifying strains, Maui Wowie is near the bottom for THC in our dataset: its 18.18% median total THC ranks 47th of 52, with Grape Ape (18.42%) just above and Cherry Diesel (18.10%) just below.¹

The 25% line tells a similar bottom-third story: 1.1% of tests got to that point or beyond, 50th overall.¹ Consistency is the counterpoint: from 16.50% to 19.65%, the middle half covers 3.15 points, the 4th tightest range among 52 qualifying strains.¹

Yes, stronger Maui Wowie carried more total terpenes in this cut: among 132 results with both measures, the upper THC third began at 18.71% and had a 1.71% total-terpene median, while the lower third ended at 16.78% and had 1.31%.¹

Maryland drove the state-level check: the lower-THC third had 1.31%, while the higher-THC third had 1.73%; that means the upward pattern held in 1 of 1 qualifying states.¹ By weight, total terpenes measure aroma compounds, and this comparison is not about effects.

Yes, Maui Wowie has tested stronger by year-qualified medians in our data, rising from 16.75% in 2021 on 73 tests to 18.88% in 2023 on 52 tests; the overall shift was +2.13 points.¹

Keeping only Maryland still shows an increase: 2021 had 16.75%, and 2023 had 18.79%, for +2.04 points overall.¹ Our year view excludes any year below 20 tests.¹

No, Maui Wowie was not mostly flower in the exact-name lab file: 48% of 435 results were flower, while other forms included concentrates 37%, other or unrecorded 11% and pre-rolls 2.8%.¹

Only flower is counted in this site's strain calculations. Separately, 126 lab records used longer labels containing Maui Wowie, or 23% of records where the name appeared anywhere; the leading examples were “Maui Wowie x Cherry Pie” (24), “Cherry Maui Wowie” (11) and “ABX Terp Chews Maui Wowie Gummies (100mg)” (9).¹ Because added words, cross labels and product terms may signal different material, our matching method excludes them.

Usually yes where prices were comparable: Maui Wowie priced below the same-menu benchmark in three of four markets; in the Oct 4, 2026 Weedmaps pull, 288 store listings carried its flower within 50 miles of each market center, spanning 13 of 27 markets and placing 16th of 58 tracked strains.²

Exact-eighth pricing was market-specific: Los Angeles, CA had a Maui Wowie median of $14.23 versus a same-menu benchmark of $25.00; New York, NY was $35.70 versus $36.08; Boston, MA was $30.50 versus $29.00; Oklahoma City, OK was $14.50 versus $17.75.² Across those comparisons, Maui Wowie undercut the typical same-menu strain in three of four markets.²